$VIVE News Article - Viveve Announces Positive Primary Efficacy Data from its SUI Feasibility Study and Positive Preclinical Outcomes that Support the Company's New Sham Tip for Pivotal PURSUIT Trial
https://marketwirenews.com/news-releases/vive...85220.html